These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 7823248)
1. p53 expression, mutation, and allelic deletion in ovarian cancer. McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248 [TBL] [Abstract][Full Text] [Related]
2. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP. Chen YH; Li CD; Yap EP; McGee JO J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma. Frank TS; Bartos RE; Haefner HK; Roberts JA; Wilson MD; Hubbell GP Mod Pathol; 1994 Jan; 7(1):3-8. PubMed ID: 7909153 [TBL] [Abstract][Full Text] [Related]
4. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210 [TBL] [Abstract][Full Text] [Related]
5. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
6. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546 [TBL] [Abstract][Full Text] [Related]
7. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218 [TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212 [TBL] [Abstract][Full Text] [Related]
9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
10. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Nayak BK; Baral RN; Das BR Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549 [TBL] [Abstract][Full Text] [Related]
11. p53 mutation is infrequent in clear cell carcinoma of the ovary. Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858 [TBL] [Abstract][Full Text] [Related]
12. The role of p53 mutations in bilateral breast carcinoma. Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647 [TBL] [Abstract][Full Text] [Related]
13. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563 [TBL] [Abstract][Full Text] [Related]
14. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137 [TBL] [Abstract][Full Text] [Related]
15. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
16. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma. Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734 [TBL] [Abstract][Full Text] [Related]
17. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291 [TBL] [Abstract][Full Text] [Related]
18. p53 mutations in ovarian cancer: a late event? Mazars R; Pujol P; Maudelonde T; Jeanteur P; Theillet C Oncogene; 1991 Sep; 6(9):1685-90. PubMed ID: 1923532 [TBL] [Abstract][Full Text] [Related]
19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
20. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]